Provide a structured summary of objectives, perspective, setting, methods (including study design and inputs), results (including base case and uncertainty analyses), and conclusions.
1

Introduction
Background and objectives 3
Provide an explicit statement of the broader context for the study.
2-3
Present the study question and its relevance for health policy or practice decisions. 3
Methods
Target population and subgroups 4
Describe characteristics of the base case population and subgroups analysed, including why they were chosen.
3
Setting and location 5 State relevant aspects of the system(s) in which the decision(s) need(s) to be made. 3
Study perspective 6 Describe the perspective of the study and relate this to the costs being evaluated. 6
Comparators 7 Describe the interventions or strategies being compared and state why they were chosen.
5-6
Time horizon 8
State the time horizon(s) over which costs and consequences are being evaluated and say why appropriate.
5
Discount rate 9 Report the choice of discount rate(s) used for costs and outcomes and say why appropriate.
Not applicable
Choice of health outcomes 10
Describe what outcomes were used as the measure(s) of benefit in the evaluation and their relevance for the type of analysis performed. 
Study parameters 18
Report the values, ranges, references, and, if used, probability distributions for all parameters. Report reasons or sources for distributions used to represent uncertainty where appropriate. Providing a table to show the input values is strongly recommended.
8-13
Incremental costs and outcomes 19
For each intervention, report mean values for the main categories of estimated costs and outcomes of interest, as well as mean differences between the comparator groups. If applicable, report incremental costeffectiveness ratios.
11, 13
Characterising uncertainty 20a
Single study-based economic evaluation: Describe the effects of sampling uncertainty for the estimated incremental cost and incremental effectiveness parameters, together with the impact of methodological assumptions (such as discount rate, study perspective).
8-13 20b
Model-based economic evaluation:
Describe the effects on the results of uncertainty for all input parameters, and uncertainty related to the structure of the model and assumptions.
Not applicable
Characterising heterogeneity 21
If applicable, report differences in costs, outcomes, or cost-effectiveness that can be explained by variations between subgroups of patients with different baseline characteristics or other observed variability in effects that are not reducible by more information.
Discussion
Study findings, limitations, generalisability, and current knowledge 22 Summarise key study findings and describe how they support the conclusions reached. Discuss limitations and the generalisability of the findings and how the findings fit with current knowledge.
14-16
Other
Source of funding 23
Describe how the study was funded and the role of the funder in the identification, design, conduct, and reporting of the analysis. Describe other non-monetary sources of support.
16
Conflicts of interest 24
Describe any potential for conflict of interest of study contributors in accordance with journal policy. In the absence of a journal policy, we recommend authors comply with For consistency, the CHEERS statement checklist format is based on the format of the CONSORT statement checklist Figure S1 . Cost-utility plane of 1000 bootstrap replicated incremental cost-utility from the health care perspective (completer sample): (a) MBSR vs. TAU; (b) MBSR vs. FibroQoL; (c) FibroQoL vs. TAU.
